Alexandre Wibaux

Partner

New York + 1.212.326.3829 Paris + 33.1.56.59.39.39

Connect:

Share

Ranked in 2025 as "Up and Coming" by Chambers France, Alexandre Wibaux is increasingly recognized in the market for his in-depth experience in venture capital deals. He advises international and domestic emerging companies, particularly in the digital sector. Also ranked in 2025 as a "Next Generation Partner" by The Legal 500 EMEA, he is described as "a star and clearly a standout partner" and has "great knowledge of the sector, relentless and impeccable support on corporate/commercial/fundraising/acquisition subjects."

Alexandre's practice includes all fields of private equity (venture capital, growth equity, and buyouts), M&A, and capital markets.

Alexandre represents emerging growth companies (listed and not listed) in the United States and in France, as well as the private equity and industrial investors that finance them, particularly technology, internet-related, and life science companies, at every stage of development from their incorporation until their sale or IPO (initial public offering) and beyond.

His recent experience includes representing emerging growth companies Back Market, Bene Bono, Bibak, EcoVadis, Karos, Konvu, OpenClassrooms, Pigment, and Sweep and the investors Alven Capital, Chalfen Ventures, Daphni, Earlybird, Eight Roads, Elaia, Elephant, Frst, Hedosophia, henQ, Otium, Partech Ventures, Serena Capital, Singular Capital Partners, Silver Lake, Stride.VC, and Valar Ventures.

Alexandre also acted as lead or co-lead lawyer in the sales of CastorDoc, Doctrine, Youboox, Alkemics, Easyrecrue, Sentryo, and Drivy; the acquisitions of unifAI by Akeneo, ecotrek by EcoVadis, goFLUX by Karos, Monk by ACV Auctions, Qare by HealthHero, and the Optis group by ANSYS; and the offerings on Euronext and/or Nasdaq of Carmat, Cellectis, Kalray, and Verimatrix.

Experience

  • HG Ventures participates in $44 million Series B financing of VoxelJones Day advised HG Ventures in connection with the $44 million Series B financing of Voxel, the AI company revolutionizing workplace safety and risk.
  • Resonance leads $15 million Series A financing of DeepIPJones Day advised Resonance as lead investor in the $15 million Series A financing of DeepIP, a French startup that develops an AI assistant for drafting patents.
  • henQ participates in €25 million Series B financing of TomorroJones Day advised henQ in connection with the €25 million Series B financing of Tomorro, a French start-up engaged in the development of a contract management and negotiation platform.
  • CastorDoc sells Company to CoalesceJones Day advised CastorDoc, a French company that developed an AI-driven metadata management solution and is now known as Coalesce Catalog, in connection with the sale of the Company to Coalesce, a U.S. company specializing in data management and analysis.
  • Daphni and Serena lead €3 million seed financing of KleioJones Day advised Daphni and Serena as lead investors in the €3 million seed financing of Kleio, formerly Autodm AI, a French start-up developing a software specializing in conversational artificial intelligence for enterprises.
  • Chalfen Ventures and Stride.VC participate in €13 million Series A financing of KraaftJones Day advised Chalfen Ventures and Stride.VC in connection with the €13 million Series A financing of Kraaft, a French-based company which has developed a super construction worksite monitoring application.
  • Lucien Pagès sells Lucien Pagès group to The IndependentsJones Day advised Lucien Pagès, as seller, in the sale of the Lucien Pagès group to The Independents.
  • Chalfen Ventures leads $18 million Series A financing of Polar AnalyticsJones Day advised Chalfen Ventures as lead investor in the $18 million Series A financing of Polar Analytics, a French startup that develops software empowering consumer brands.
  • Alven Capital participates in $15 million Series A financing of Archy DentalJones Day assisted Alven Capital Partners in connection with the $15 million Series A financing of Archy Dental, an AI-powered, cloud-based platform designed specifically for dental practices by automating key processes, improving patient care, and allowing practices to run more efficiently.
  • Serena Capital participates in €2.66 million pre-seed financing of EdgeeJones Day advised Serena Capital in connection with the €2.66 million pre-seed financing of Edgee, a French company engaged in software development for edge computers.
  • Affiliates of Centre Lane Partners acquire substantially all of the assets of Hardinge Inc. and its subsidiaries, including the Kellenberger, USACH, SuperPrecision, and Workholding business linesJones Day advised affiliates of Centre Lane Partners in the acquisition of substantially all of the assets of Hardinge Inc. and its debtor subsidiaries, a global leader and provider of advanced machine tool, manufacturing and workholding solutions, as part of chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware.
  • Hedosophia leads €50 million Series A financing of NEATJones Day advised Hedosophia in connection with the €50 million Series A financing of NEAT, a French start-up operating as an embedded insurance broker.
  • Alven Capital Partners leads $14 million Series A financing of AttentionJones Day represented Alven Capital Partners as lead investor in the $14 million Series A financing of Attention, a platform that transforms customer conversations into actionable insights, offering sales teams a powerful tool to close more deals.
  • Zebra Impact Ventures leads $37 million Series B financing of AgroSpheresJones Day represented Zebra Impact Ventures as lead investor in the $37 million Series B financing of AgroSpheres Inc., a biotechnology leader in sustainable crop protection and crop health.
  • Myeloma Investment Fund invests in Nammi Therapeutics, Inc.'s Series B financingJones Day advised Myeloma Investment Fund in $1 million investment in Nammi Therapeutics, Inc.'s Series B financing.
  • Partech Partners leads €37 million Series B financing of CintooJones Day represented Partech Partners as lead investor in the €37 million Series B financing of Cintoo, the leading provider of cloud-based Reality Data management and collaboration solutions.
  • Skycatcher leads €10 million financing of SekaiJones Day advised Skycatcher in leading the €10 million financing of Sekai, a French start-up specializing in the development of mobile applications for better anime experiences.
  • Konvu raises $5 million in Series A seed financingJones Day advised Konvu, a provider of application security solutions, in connection with its $5 million seed Series A financing.
  • Silver Lake Waterman, Eurazeo, Partech Partners, Eight Roads, F-Prime, and Serena Capital participate in $54 million Series C financing of OdasevaJones Day advised Silver Lake Waterman, the lead new investor, and Eurazeo, a new investor, as well as historical investors Partech Partners, Eight Roads, F-Prime and Serena Capital in connection with the $54 million Series C financing of Odaseva, the leading enterprise data security platform for Salesforce, along with new investor Crescent Cove.
  • henQ participates in €25 million Series A financing of imaginoJones Day advised henQ in connection with the €25 million Series A financing of imagino, a revenue-first customer experience platform providing brands with clear and actionable insights through its Customer Data Platform (CDP) to enhance their marketing campaigns.
    • View All

    November 2024 Podcast

    JONES DAY TALKS®: The Five Pillars of Protection for Later Stage VC Investors

    November 20, 2024 Firm Hosted

    Considerations For the Development and Licensing of Patent Portfolios

    September 2024 Podcast

    JONES DAY TALKS®: A Trip to the Dark Side – Venture Capital Down Rounds and Recaps

    November 20, 2024 Firm Hosted

    Considerations For the Development and Licensing of Patent Portfolios

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.